U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H12NO6P
Molecular Weight 249.1577
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PYRIDOXINE PHOSPHATE

SMILES

CC1=NC=C(COP(O)(O)=O)C(CO)=C1O

InChI

InChIKey=WHOMFKWHIQZTHY-UHFFFAOYSA-N
InChI=1S/C8H12NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2,10-11H,3-4H2,1H3,(H2,12,13,14)

HIDE SMILES / InChI

Molecular Formula C8H12NO6P
Molecular Weight 249.1577
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Pyridoxine-phosphate is a vitamer of Vitamin B6. In man vitamin B(6) ingested from the diet exists as six different vitamers, pyridoxal (PL), pyridoxamine (PM), pyridoxine (PN), pyridoxal 5'-phosphate (PLP), pyridoxamine 5'- phosphate (PMP) and pyridoxine 5'-phosphate (PNP). It is a substrate for pyridoxine-5'-phosphate oxidase (PNPO) and pyridoxal phosphate phosphatase (PDXP). PNPO deficiency is responsible of severe neonatal encephalopathy.

CNS Activity

Curator's Comment: Known to be CNS penetrant in rat. Human data not available.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
CSF glutamate/GABA concentrations in pyridoxine-dependent seizures: etiology of pyridoxine-dependent seizures and the mechanisms of pyridoxine action in seizure control.
2001 Mar
Multistate binding in pyridoxine 5'-phosphate synthase: 1.96 A crystal structure in complex with 1-deoxy-D-xylulose phosphate.
2002 Oct 1
Genome-based construction of the metabolic pathways of Orientia tsutsugamushi and comparative analysis within the Rickettsiales order.
2008
Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis.
2008 Jul
Human brain pyridoxal-5'-phosphate phosphatase (PLPP):protein transduction of PEP-1-PLPP into PC12 cells.
2008 May 31
Pyridoxal phosphate-dependent neonatal epileptic encephalopathy.
2009
Pyridoxine 5'-phosphate oxidase, not pyridoxal kinase, involves in long-term potentiation induction in the rat dentate gyrus.
2009 Jan
Enhanced pyridoxal 5'-phosphate synthetic enzyme immunoreactivities do not contribute to GABAergic inhibition in the rat hippocampus following pilocarpine-induced status epilepticus.
2009 Mar 31
Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.
2009 Oct 6
Pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency: unique clinical symptoms and non-specific EEG characteristics.
2010 Jul
Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.
2010 Jul
Proteomic analysis of aging brain in SAMP10 mouse: a model of age-related cerebral degeneration.
2010 Jun
A genomic perspective on the potential of Actinobacillus succinogenes for industrial succinate production.
2010 Nov 30
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: [3H]pyridoxine-P
Single injection of 10 ug of pyridoxine-phosphate.
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:45:28 GMT 2023
Edited
by admin
on Fri Dec 15 19:45:28 GMT 2023
Record UNII
RG20W8WYLS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PYRIDOXINE PHOSPHATE
WHO-DD  
Common Name English
VITAMIN B6 (PYRIDOXINE PHOSPHATE)
Common Name English
NSC-83119
Code English
Pyridoxine phosphate [WHO-DD]
Common Name English
PYRIDOXINE 5-PHOSPHATE
Common Name English
3,4-PYRIDINEDIMETHANOL, 5-HYDROXY-6-METHYL-, .ALPHA.3-(DIHYDROGEN PHOSPHATE)
Systematic Name English
Code System Code Type Description
FDA UNII
RG20W8WYLS
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
EVMPD
SUB23137
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-179-6
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
DRUG BANK
DB02209
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
CAS
447-05-2
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
NSC
83119
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
SMS_ID
100000088839
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
EPA CompTox
DTXSID80196278
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
PUBCHEM
1055
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
CHEBI
28803
Created by admin on Fri Dec 15 19:45:28 GMT 2023 , Edited by admin on Fri Dec 15 19:45:28 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE ACTIVE
MAJOR
Related Record Type Details
ACTIVE MOIETY